ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Clinical Oncology Next Generation Sequencing Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-7S8537
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global and Japan Clinical Oncology Next Generation Sequencing Market Size Status and Forecast 2021 2027
BUY CHAPTERS

Global Clinical Oncology Next Generation Sequencing Market Research Report 2025

Code: QYRE-Auto-7S8537
Report
September 2025
Pages:90
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Illumina Inc
Thermo Fisher Scientific
F Hoffmann La Roche Ltd
Agilent Technologies
Myriad Genetics
Beijing Genomics Institute (BGI)
Perkin Elmer
Foundation Medicine
Pacific Bioscience
Oxford Nanopore Technologies, Ltd.
Paradigm Diagnostics
Caris Life Sciences
Partek
Eurofins Scientific S.E.
QIAGEN N V

Clinical Oncology Next Generation Sequencing Market

The global market for Clinical Oncology Next Generation Sequencing was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Next generation sequencing (NGS) has created a noteworthy paradigm shift in the clinical diagnostic field. It refers to an aggregate collection of methods in which various sequencing reactions occur at the same time, bringing about vast amounts of sequencing data for a little division of the cost of Sanger sequencing.
North American market for Clinical Oncology Next Generation Sequencing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Clinical Oncology Next Generation Sequencing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Clinical Oncology Next Generation Sequencing in Hospitals is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Clinical Oncology Next Generation Sequencing include Illumina, Inc., Thermo Fisher Scientific, F. Hoffmann-La Roche Ltd., Agilent Technologies, Myriad Genetics, Beijing Genomics Institute (BGI), Perkin Elmer, Foundation Medicine, Pacific Bioscience, Oxford Nanopore Technologies Ltd., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Clinical Oncology Next Generation Sequencing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Clinical Oncology Next Generation Sequencing.
The Clinical Oncology Next Generation Sequencing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Clinical Oncology Next Generation Sequencing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Clinical Oncology Next Generation Sequencing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Clinical Oncology Next Generation Sequencing Market Report

Report Metric Details
Report Name Clinical Oncology Next Generation Sequencing Market
Segment by Type
  • Whole Genome Sequencing
  • Whole Exome Sequencing
  • Targeted Sequencing & Resequencing Centrifuges
Segment by Application
  • Hospitals
  • Clinics
  • Laboratories
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Illumina, Inc., Thermo Fisher Scientific, F. Hoffmann-La Roche Ltd., Agilent Technologies, Myriad Genetics, Beijing Genomics Institute (BGI), Perkin Elmer, Foundation Medicine, Pacific Bioscience, Oxford Nanopore Technologies Ltd., Paradigm Diagnostics, Caris Life Sciences, Partek, Inc., Eurofins Scientific S.E., Qiagen N.V.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Clinical Oncology Next Generation Sequencing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Clinical Oncology Next Generation Sequencing Market report?

Ans: The main players in the Clinical Oncology Next Generation Sequencing Market are Illumina, Inc., Thermo Fisher Scientific, F. Hoffmann-La Roche Ltd., Agilent Technologies, Myriad Genetics, Beijing Genomics Institute (BGI), Perkin Elmer, Foundation Medicine, Pacific Bioscience, Oxford Nanopore Technologies Ltd., Paradigm Diagnostics, Caris Life Sciences, Partek, Inc., Eurofins Scientific S.E., Qiagen N.V.

What are the Application segmentation covered in the Clinical Oncology Next Generation Sequencing Market report?

Ans: The Applications covered in the Clinical Oncology Next Generation Sequencing Market report are Hospitals, Clinics, Laboratories

What are the Type segmentation covered in the Clinical Oncology Next Generation Sequencing Market report?

Ans: The Types covered in the Clinical Oncology Next Generation Sequencing Market report are Whole Genome Sequencing, Whole Exome Sequencing, Targeted Sequencing & Resequencing Centrifuges

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Clinical Oncology Next Generation Sequencing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Whole Genome Sequencing
1.2.3 Whole Exome Sequencing
1.2.4 Targeted Sequencing & Resequencing Centrifuges
1.3 Market by Application
1.3.1 Global Clinical Oncology Next Generation Sequencing Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Laboratories
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Clinical Oncology Next Generation Sequencing Market Perspective (2020-2031)
2.2 Global Clinical Oncology Next Generation Sequencing Growth Trends by Region
2.2.1 Global Clinical Oncology Next Generation Sequencing Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Clinical Oncology Next Generation Sequencing Historic Market Size by Region (2020-2025)
2.2.3 Clinical Oncology Next Generation Sequencing Forecasted Market Size by Region (2026-2031)
2.3 Clinical Oncology Next Generation Sequencing Market Dynamics
2.3.1 Clinical Oncology Next Generation Sequencing Industry Trends
2.3.2 Clinical Oncology Next Generation Sequencing Market Drivers
2.3.3 Clinical Oncology Next Generation Sequencing Market Challenges
2.3.4 Clinical Oncology Next Generation Sequencing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Clinical Oncology Next Generation Sequencing Players by Revenue
3.1.1 Global Top Clinical Oncology Next Generation Sequencing Players by Revenue (2020-2025)
3.1.2 Global Clinical Oncology Next Generation Sequencing Revenue Market Share by Players (2020-2025)
3.2 Global Clinical Oncology Next Generation Sequencing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Clinical Oncology Next Generation Sequencing Revenue
3.4 Global Clinical Oncology Next Generation Sequencing Market Concentration Ratio
3.4.1 Global Clinical Oncology Next Generation Sequencing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Clinical Oncology Next Generation Sequencing Revenue in 2024
3.5 Global Key Players of Clinical Oncology Next Generation Sequencing Head office and Area Served
3.6 Global Key Players of Clinical Oncology Next Generation Sequencing, Product and Application
3.7 Global Key Players of Clinical Oncology Next Generation Sequencing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Clinical Oncology Next Generation Sequencing Breakdown Data by Type
4.1 Global Clinical Oncology Next Generation Sequencing Historic Market Size by Type (2020-2025)
4.2 Global Clinical Oncology Next Generation Sequencing Forecasted Market Size by Type (2026-2031)
5 Clinical Oncology Next Generation Sequencing Breakdown Data by Application
5.1 Global Clinical Oncology Next Generation Sequencing Historic Market Size by Application (2020-2025)
5.2 Global Clinical Oncology Next Generation Sequencing Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Clinical Oncology Next Generation Sequencing Market Size (2020-2031)
6.2 North America Clinical Oncology Next Generation Sequencing Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Clinical Oncology Next Generation Sequencing Market Size by Country (2020-2025)
6.4 North America Clinical Oncology Next Generation Sequencing Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Clinical Oncology Next Generation Sequencing Market Size (2020-2031)
7.2 Europe Clinical Oncology Next Generation Sequencing Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Clinical Oncology Next Generation Sequencing Market Size by Country (2020-2025)
7.4 Europe Clinical Oncology Next Generation Sequencing Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Clinical Oncology Next Generation Sequencing Market Size (2020-2031)
8.2 Asia-Pacific Clinical Oncology Next Generation Sequencing Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Clinical Oncology Next Generation Sequencing Market Size by Region (2020-2025)
8.4 Asia-Pacific Clinical Oncology Next Generation Sequencing Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Clinical Oncology Next Generation Sequencing Market Size (2020-2031)
9.2 Latin America Clinical Oncology Next Generation Sequencing Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Clinical Oncology Next Generation Sequencing Market Size by Country (2020-2025)
9.4 Latin America Clinical Oncology Next Generation Sequencing Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Clinical Oncology Next Generation Sequencing Market Size (2020-2031)
10.2 Middle East & Africa Clinical Oncology Next Generation Sequencing Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Clinical Oncology Next Generation Sequencing Market Size by Country (2020-2025)
10.4 Middle East & Africa Clinical Oncology Next Generation Sequencing Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Illumina, Inc.
11.1.1 Illumina, Inc. Company Details
11.1.2 Illumina, Inc. Business Overview
11.1.3 Illumina, Inc. Clinical Oncology Next Generation Sequencing Introduction
11.1.4 Illumina, Inc. Revenue in Clinical Oncology Next Generation Sequencing Business (2020-2025)
11.1.5 Illumina, Inc. Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Clinical Oncology Next Generation Sequencing Introduction
11.2.4 Thermo Fisher Scientific Revenue in Clinical Oncology Next Generation Sequencing Business (2020-2025)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 F. Hoffmann-La Roche Ltd.
11.3.1 F. Hoffmann-La Roche Ltd. Company Details
11.3.2 F. Hoffmann-La Roche Ltd. Business Overview
11.3.3 F. Hoffmann-La Roche Ltd. Clinical Oncology Next Generation Sequencing Introduction
11.3.4 F. Hoffmann-La Roche Ltd. Revenue in Clinical Oncology Next Generation Sequencing Business (2020-2025)
11.3.5 F. Hoffmann-La Roche Ltd. Recent Development
11.4 Agilent Technologies
11.4.1 Agilent Technologies Company Details
11.4.2 Agilent Technologies Business Overview
11.4.3 Agilent Technologies Clinical Oncology Next Generation Sequencing Introduction
11.4.4 Agilent Technologies Revenue in Clinical Oncology Next Generation Sequencing Business (2020-2025)
11.4.5 Agilent Technologies Recent Development
11.5 Myriad Genetics
11.5.1 Myriad Genetics Company Details
11.5.2 Myriad Genetics Business Overview
11.5.3 Myriad Genetics Clinical Oncology Next Generation Sequencing Introduction
11.5.4 Myriad Genetics Revenue in Clinical Oncology Next Generation Sequencing Business (2020-2025)
11.5.5 Myriad Genetics Recent Development
11.6 Beijing Genomics Institute (BGI)
11.6.1 Beijing Genomics Institute (BGI) Company Details
11.6.2 Beijing Genomics Institute (BGI) Business Overview
11.6.3 Beijing Genomics Institute (BGI) Clinical Oncology Next Generation Sequencing Introduction
11.6.4 Beijing Genomics Institute (BGI) Revenue in Clinical Oncology Next Generation Sequencing Business (2020-2025)
11.6.5 Beijing Genomics Institute (BGI) Recent Development
11.7 Perkin Elmer
11.7.1 Perkin Elmer Company Details
11.7.2 Perkin Elmer Business Overview
11.7.3 Perkin Elmer Clinical Oncology Next Generation Sequencing Introduction
11.7.4 Perkin Elmer Revenue in Clinical Oncology Next Generation Sequencing Business (2020-2025)
11.7.5 Perkin Elmer Recent Development
11.8 Foundation Medicine
11.8.1 Foundation Medicine Company Details
11.8.2 Foundation Medicine Business Overview
11.8.3 Foundation Medicine Clinical Oncology Next Generation Sequencing Introduction
11.8.4 Foundation Medicine Revenue in Clinical Oncology Next Generation Sequencing Business (2020-2025)
11.8.5 Foundation Medicine Recent Development
11.9 Pacific Bioscience
11.9.1 Pacific Bioscience Company Details
11.9.2 Pacific Bioscience Business Overview
11.9.3 Pacific Bioscience Clinical Oncology Next Generation Sequencing Introduction
11.9.4 Pacific Bioscience Revenue in Clinical Oncology Next Generation Sequencing Business (2020-2025)
11.9.5 Pacific Bioscience Recent Development
11.10 Oxford Nanopore Technologies Ltd.
11.10.1 Oxford Nanopore Technologies Ltd. Company Details
11.10.2 Oxford Nanopore Technologies Ltd. Business Overview
11.10.3 Oxford Nanopore Technologies Ltd. Clinical Oncology Next Generation Sequencing Introduction
11.10.4 Oxford Nanopore Technologies Ltd. Revenue in Clinical Oncology Next Generation Sequencing Business (2020-2025)
11.10.5 Oxford Nanopore Technologies Ltd. Recent Development
11.11 Paradigm Diagnostics
11.11.1 Paradigm Diagnostics Company Details
11.11.2 Paradigm Diagnostics Business Overview
11.11.3 Paradigm Diagnostics Clinical Oncology Next Generation Sequencing Introduction
11.11.4 Paradigm Diagnostics Revenue in Clinical Oncology Next Generation Sequencing Business (2020-2025)
11.11.5 Paradigm Diagnostics Recent Development
11.12 Caris Life Sciences
11.12.1 Caris Life Sciences Company Details
11.12.2 Caris Life Sciences Business Overview
11.12.3 Caris Life Sciences Clinical Oncology Next Generation Sequencing Introduction
11.12.4 Caris Life Sciences Revenue in Clinical Oncology Next Generation Sequencing Business (2020-2025)
11.12.5 Caris Life Sciences Recent Development
11.13 Partek, Inc.
11.13.1 Partek, Inc. Company Details
11.13.2 Partek, Inc. Business Overview
11.13.3 Partek, Inc. Clinical Oncology Next Generation Sequencing Introduction
11.13.4 Partek, Inc. Revenue in Clinical Oncology Next Generation Sequencing Business (2020-2025)
11.13.5 Partek, Inc. Recent Development
11.14 Eurofins Scientific S.E.
11.14.1 Eurofins Scientific S.E. Company Details
11.14.2 Eurofins Scientific S.E. Business Overview
11.14.3 Eurofins Scientific S.E. Clinical Oncology Next Generation Sequencing Introduction
11.14.4 Eurofins Scientific S.E. Revenue in Clinical Oncology Next Generation Sequencing Business (2020-2025)
11.14.5 Eurofins Scientific S.E. Recent Development
11.15 Qiagen N.V.
11.15.1 Qiagen N.V. Company Details
11.15.2 Qiagen N.V. Business Overview
11.15.3 Qiagen N.V. Clinical Oncology Next Generation Sequencing Introduction
11.15.4 Qiagen N.V. Revenue in Clinical Oncology Next Generation Sequencing Business (2020-2025)
11.15.5 Qiagen N.V. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Illumina Inc
Thermo Fisher Scientific
F Hoffmann La Roche Ltd
Agilent Technologies
Myriad Genetics
Beijing Genomics Institute (BGI)
Perkin Elmer
Foundation Medicine
Pacific Bioscience
Oxford Nanopore Technologies, Ltd.
Paradigm Diagnostics
Caris Life Sciences
Partek
Eurofins Scientific S.E.
QIAGEN N V
List of Tables
 Table 1. Global Clinical Oncology Next Generation Sequencing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Whole Genome Sequencing
 Table 3. Key Players of Whole Exome Sequencing
 Table 4. Key Players of Targeted Sequencing & Resequencing Centrifuges
 Table 5. Global Clinical Oncology Next Generation Sequencing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Clinical Oncology Next Generation Sequencing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Clinical Oncology Next Generation Sequencing Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global Clinical Oncology Next Generation Sequencing Market Share by Region (2020-2025)
 Table 9. Global Clinical Oncology Next Generation Sequencing Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global Clinical Oncology Next Generation Sequencing Market Share by Region (2026-2031)
 Table 11. Clinical Oncology Next Generation Sequencing Market Trends
 Table 12. Clinical Oncology Next Generation Sequencing Market Drivers
 Table 13. Clinical Oncology Next Generation Sequencing Market Challenges
 Table 14. Clinical Oncology Next Generation Sequencing Market Restraints
 Table 15. Global Clinical Oncology Next Generation Sequencing Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global Clinical Oncology Next Generation Sequencing Market Share by Players (2020-2025)
 Table 17. Global Top Clinical Oncology Next Generation Sequencing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Oncology Next Generation Sequencing as of 2024)
 Table 18. Ranking of Global Top Clinical Oncology Next Generation Sequencing Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by Clinical Oncology Next Generation Sequencing Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of Clinical Oncology Next Generation Sequencing, Headquarters and Area Served
 Table 21. Global Key Players of Clinical Oncology Next Generation Sequencing, Product and Application
 Table 22. Global Key Players of Clinical Oncology Next Generation Sequencing, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Clinical Oncology Next Generation Sequencing Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global Clinical Oncology Next Generation Sequencing Revenue Market Share by Type (2020-2025)
 Table 26. Global Clinical Oncology Next Generation Sequencing Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global Clinical Oncology Next Generation Sequencing Revenue Market Share by Type (2026-2031)
 Table 28. Global Clinical Oncology Next Generation Sequencing Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global Clinical Oncology Next Generation Sequencing Revenue Market Share by Application (2020-2025)
 Table 30. Global Clinical Oncology Next Generation Sequencing Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global Clinical Oncology Next Generation Sequencing Revenue Market Share by Application (2026-2031)
 Table 32. North America Clinical Oncology Next Generation Sequencing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America Clinical Oncology Next Generation Sequencing Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America Clinical Oncology Next Generation Sequencing Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe Clinical Oncology Next Generation Sequencing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe Clinical Oncology Next Generation Sequencing Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe Clinical Oncology Next Generation Sequencing Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific Clinical Oncology Next Generation Sequencing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific Clinical Oncology Next Generation Sequencing Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific Clinical Oncology Next Generation Sequencing Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America Clinical Oncology Next Generation Sequencing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America Clinical Oncology Next Generation Sequencing Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America Clinical Oncology Next Generation Sequencing Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa Clinical Oncology Next Generation Sequencing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa Clinical Oncology Next Generation Sequencing Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa Clinical Oncology Next Generation Sequencing Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Illumina, Inc. Company Details
 Table 48. Illumina, Inc. Business Overview
 Table 49. Illumina, Inc. Clinical Oncology Next Generation Sequencing Product
 Table 50. Illumina, Inc. Revenue in Clinical Oncology Next Generation Sequencing Business (2020-2025) & (US$ Million)
 Table 51. Illumina, Inc. Recent Development
 Table 52. Thermo Fisher Scientific Company Details
 Table 53. Thermo Fisher Scientific Business Overview
 Table 54. Thermo Fisher Scientific Clinical Oncology Next Generation Sequencing Product
 Table 55. Thermo Fisher Scientific Revenue in Clinical Oncology Next Generation Sequencing Business (2020-2025) & (US$ Million)
 Table 56. Thermo Fisher Scientific Recent Development
 Table 57. F. Hoffmann-La Roche Ltd. Company Details
 Table 58. F. Hoffmann-La Roche Ltd. Business Overview
 Table 59. F. Hoffmann-La Roche Ltd. Clinical Oncology Next Generation Sequencing Product
 Table 60. F. Hoffmann-La Roche Ltd. Revenue in Clinical Oncology Next Generation Sequencing Business (2020-2025) & (US$ Million)
 Table 61. F. Hoffmann-La Roche Ltd. Recent Development
 Table 62. Agilent Technologies Company Details
 Table 63. Agilent Technologies Business Overview
 Table 64. Agilent Technologies Clinical Oncology Next Generation Sequencing Product
 Table 65. Agilent Technologies Revenue in Clinical Oncology Next Generation Sequencing Business (2020-2025) & (US$ Million)
 Table 66. Agilent Technologies Recent Development
 Table 67. Myriad Genetics Company Details
 Table 68. Myriad Genetics Business Overview
 Table 69. Myriad Genetics Clinical Oncology Next Generation Sequencing Product
 Table 70. Myriad Genetics Revenue in Clinical Oncology Next Generation Sequencing Business (2020-2025) & (US$ Million)
 Table 71. Myriad Genetics Recent Development
 Table 72. Beijing Genomics Institute (BGI) Company Details
 Table 73. Beijing Genomics Institute (BGI) Business Overview
 Table 74. Beijing Genomics Institute (BGI) Clinical Oncology Next Generation Sequencing Product
 Table 75. Beijing Genomics Institute (BGI) Revenue in Clinical Oncology Next Generation Sequencing Business (2020-2025) & (US$ Million)
 Table 76. Beijing Genomics Institute (BGI) Recent Development
 Table 77. Perkin Elmer Company Details
 Table 78. Perkin Elmer Business Overview
 Table 79. Perkin Elmer Clinical Oncology Next Generation Sequencing Product
 Table 80. Perkin Elmer Revenue in Clinical Oncology Next Generation Sequencing Business (2020-2025) & (US$ Million)
 Table 81. Perkin Elmer Recent Development
 Table 82. Foundation Medicine Company Details
 Table 83. Foundation Medicine Business Overview
 Table 84. Foundation Medicine Clinical Oncology Next Generation Sequencing Product
 Table 85. Foundation Medicine Revenue in Clinical Oncology Next Generation Sequencing Business (2020-2025) & (US$ Million)
 Table 86. Foundation Medicine Recent Development
 Table 87. Pacific Bioscience Company Details
 Table 88. Pacific Bioscience Business Overview
 Table 89. Pacific Bioscience Clinical Oncology Next Generation Sequencing Product
 Table 90. Pacific Bioscience Revenue in Clinical Oncology Next Generation Sequencing Business (2020-2025) & (US$ Million)
 Table 91. Pacific Bioscience Recent Development
 Table 92. Oxford Nanopore Technologies Ltd. Company Details
 Table 93. Oxford Nanopore Technologies Ltd. Business Overview
 Table 94. Oxford Nanopore Technologies Ltd. Clinical Oncology Next Generation Sequencing Product
 Table 95. Oxford Nanopore Technologies Ltd. Revenue in Clinical Oncology Next Generation Sequencing Business (2020-2025) & (US$ Million)
 Table 96. Oxford Nanopore Technologies Ltd. Recent Development
 Table 97. Paradigm Diagnostics Company Details
 Table 98. Paradigm Diagnostics Business Overview
 Table 99. Paradigm Diagnostics Clinical Oncology Next Generation Sequencing Product
 Table 100. Paradigm Diagnostics Revenue in Clinical Oncology Next Generation Sequencing Business (2020-2025) & (US$ Million)
 Table 101. Paradigm Diagnostics Recent Development
 Table 102. Caris Life Sciences Company Details
 Table 103. Caris Life Sciences Business Overview
 Table 104. Caris Life Sciences Clinical Oncology Next Generation Sequencing Product
 Table 105. Caris Life Sciences Revenue in Clinical Oncology Next Generation Sequencing Business (2020-2025) & (US$ Million)
 Table 106. Caris Life Sciences Recent Development
 Table 107. Partek, Inc. Company Details
 Table 108. Partek, Inc. Business Overview
 Table 109. Partek, Inc. Clinical Oncology Next Generation Sequencing Product
 Table 110. Partek, Inc. Revenue in Clinical Oncology Next Generation Sequencing Business (2020-2025) & (US$ Million)
 Table 111. Partek, Inc. Recent Development
 Table 112. Eurofins Scientific S.E. Company Details
 Table 113. Eurofins Scientific S.E. Business Overview
 Table 114. Eurofins Scientific S.E. Clinical Oncology Next Generation Sequencing Product
 Table 115. Eurofins Scientific S.E. Revenue in Clinical Oncology Next Generation Sequencing Business (2020-2025) & (US$ Million)
 Table 116. Eurofins Scientific S.E. Recent Development
 Table 117. Qiagen N.V. Company Details
 Table 118. Qiagen N.V. Business Overview
 Table 119. Qiagen N.V. Clinical Oncology Next Generation Sequencing Product
 Table 120. Qiagen N.V. Revenue in Clinical Oncology Next Generation Sequencing Business (2020-2025) & (US$ Million)
 Table 121. Qiagen N.V. Recent Development
 Table 122. Research Programs/Design for This Report
 Table 123. Key Data Information from Secondary Sources
 Table 124. Key Data Information from Primary Sources
 Table 125. Authors List of This Report


List of Figures
 Figure 1. Clinical Oncology Next Generation Sequencing Picture
 Figure 2. Global Clinical Oncology Next Generation Sequencing Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Clinical Oncology Next Generation Sequencing Market Share by Type: 2024 VS 2031
 Figure 4. Whole Genome Sequencing Features
 Figure 5. Whole Exome Sequencing Features
 Figure 6. Targeted Sequencing & Resequencing Centrifuges Features
 Figure 7. Global Clinical Oncology Next Generation Sequencing Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global Clinical Oncology Next Generation Sequencing Market Share by Application: 2024 VS 2031
 Figure 9. Hospitals Case Studies
 Figure 10. Clinics Case Studies
 Figure 11. Laboratories Case Studies
 Figure 12. Clinical Oncology Next Generation Sequencing Report Years Considered
 Figure 13. Global Clinical Oncology Next Generation Sequencing Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global Clinical Oncology Next Generation Sequencing Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Clinical Oncology Next Generation Sequencing Market Share by Region: 2024 VS 2031
 Figure 16. Global Clinical Oncology Next Generation Sequencing Market Share by Players in 2024
 Figure 17. Global Top Clinical Oncology Next Generation Sequencing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Oncology Next Generation Sequencing as of 2024)
 Figure 18. The Top 10 and 5 Players Market Share by Clinical Oncology Next Generation Sequencing Revenue in 2024
 Figure 19. North America Clinical Oncology Next Generation Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America Clinical Oncology Next Generation Sequencing Market Share by Country (2020-2031)
 Figure 21. United States Clinical Oncology Next Generation Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada Clinical Oncology Next Generation Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Clinical Oncology Next Generation Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Clinical Oncology Next Generation Sequencing Market Share by Country (2020-2031)
 Figure 25. Germany Clinical Oncology Next Generation Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France Clinical Oncology Next Generation Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. Clinical Oncology Next Generation Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy Clinical Oncology Next Generation Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia Clinical Oncology Next Generation Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries Clinical Oncology Next Generation Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Clinical Oncology Next Generation Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Clinical Oncology Next Generation Sequencing Market Share by Region (2020-2031)
 Figure 33. China Clinical Oncology Next Generation Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan Clinical Oncology Next Generation Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea Clinical Oncology Next Generation Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia Clinical Oncology Next Generation Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India Clinical Oncology Next Generation Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia Clinical Oncology Next Generation Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Clinical Oncology Next Generation Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Clinical Oncology Next Generation Sequencing Market Share by Country (2020-2031)
 Figure 41. Mexico Clinical Oncology Next Generation Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil Clinical Oncology Next Generation Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Clinical Oncology Next Generation Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Clinical Oncology Next Generation Sequencing Market Share by Country (2020-2031)
 Figure 45. Turkey Clinical Oncology Next Generation Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia Clinical Oncology Next Generation Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE Clinical Oncology Next Generation Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Illumina, Inc. Revenue Growth Rate in Clinical Oncology Next Generation Sequencing Business (2020-2025)
 Figure 49. Thermo Fisher Scientific Revenue Growth Rate in Clinical Oncology Next Generation Sequencing Business (2020-2025)
 Figure 50. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Clinical Oncology Next Generation Sequencing Business (2020-2025)
 Figure 51. Agilent Technologies Revenue Growth Rate in Clinical Oncology Next Generation Sequencing Business (2020-2025)
 Figure 52. Myriad Genetics Revenue Growth Rate in Clinical Oncology Next Generation Sequencing Business (2020-2025)
 Figure 53. Beijing Genomics Institute (BGI) Revenue Growth Rate in Clinical Oncology Next Generation Sequencing Business (2020-2025)
 Figure 54. Perkin Elmer Revenue Growth Rate in Clinical Oncology Next Generation Sequencing Business (2020-2025)
 Figure 55. Foundation Medicine Revenue Growth Rate in Clinical Oncology Next Generation Sequencing Business (2020-2025)
 Figure 56. Pacific Bioscience Revenue Growth Rate in Clinical Oncology Next Generation Sequencing Business (2020-2025)
 Figure 57. Oxford Nanopore Technologies Ltd. Revenue Growth Rate in Clinical Oncology Next Generation Sequencing Business (2020-2025)
 Figure 58. Paradigm Diagnostics Revenue Growth Rate in Clinical Oncology Next Generation Sequencing Business (2020-2025)
 Figure 59. Caris Life Sciences Revenue Growth Rate in Clinical Oncology Next Generation Sequencing Business (2020-2025)
 Figure 60. Partek, Inc. Revenue Growth Rate in Clinical Oncology Next Generation Sequencing Business (2020-2025)
 Figure 61. Eurofins Scientific S.E. Revenue Growth Rate in Clinical Oncology Next Generation Sequencing Business (2020-2025)
 Figure 62. Qiagen N.V. Revenue Growth Rate in Clinical Oncology Next Generation Sequencing Business (2020-2025)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

Global Next Generation Sequencing Data Analysis Market Research Report 2024
Global Clinical Next Generation Sequencing Market Insights Forecast to 2030
Global Next Generation Sequencing Market Research Report 2025
Global Next Generation Sequencing Technology Market Research Report 2025
Global Next Generation Sequencing NGS Services Market Research Report 2024
Next Generation Sequencing NGS Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
dna next generation sequencing market
NGS Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Next Generation Sequencing NGS Solution Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global High Throughput Sequencing NGS Market Research Report 2024
Global Next Generation Sequencing NGS Kits Market Research Report 2025
Global Next Generation Sequencing NGS Software Market Research Report 2025
Global Next Generation Sequencing Sample Preparation Market Research Report 2024
Global RNA Next Generation Sequencing Market Research Report 2024
Next Generation Sequencing NGS Product Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Clinical Next Generation Sequencing NGS Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Next Generation Oncology Solution Market Research Report 2024
Global Tumor NGS Genetic Testing Market Research Report 2024
Global Next Generation Sequencing NGS Data Analysis Market Research Report 2024
Global Sequencing Consumables Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions